laboratory reporting over direct background & implementation guidance

21
Laboratory Reporting Over Direct Background & Implementation Guidance June 19, 2012

Upload: fran

Post on 25-Feb-2016

45 views

Category:

Documents


0 download

DESCRIPTION

Laboratory Reporting Over Direct Background & Implementation Guidance. June 19, 2012. Background. States and other implementation geographies have plans to utilize Direct for reporting of laboratory results to meet Meaningful Use requirements, especially for underserved communities - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Laboratory Reporting Over Direct Background & Implementation Guidance

Laboratory Reporting Over DirectBackground & Implementation Guidance

June 19, 2012

Page 2: Laboratory Reporting Over Direct Background & Implementation Guidance

2

Background

• States and other implementation geographies have plans to utilize Direct for reporting of laboratory results to meet Meaningful Use requirements, especially for underserved communities

• The laboratory industry was not moving to adopt Direct for reporting laboratory results (in particular, the “report of record”)

• Concerns were expressed regarding the impact of Direct on laboratory accreditation

• Specific issues raised:– CLIA regulations and guidance

– Reliability of Direct for laboratory reporting

– Operational issues related to Direct

– Security of Direct

Page 3: Laboratory Reporting Over Direct Background & Implementation Guidance

3

• Congress passed the Clinical Laboratory Improvement Amendments (CLIA) in 1988 establishing quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results regardless of where the test was performed.

• The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). In total, CLIA covers approximately 225,000 laboratory entities. The Division of Laboratory Services, within the Survey and Certification Group, under the Office of Clinical Standards and Quality (OCSQ) has the responsibility for implementing the CLIA Program.

• Exempt states – New York, Washington

What is CLIA?

Page 4: Laboratory Reporting Over Direct Background & Implementation Guidance

4

Clinical Laboratory DemographicsDivision of Laboratory Services -- June 2011

Enrollment Number of Labs Number of POLs

Laboratories Registered 225,746 114,461

CLIA Exempt States Number of Labs

New York 3,336

Washington 3,466

Accreditation Organization Number of Labs

COLA 6,623

College of American Pathologists 5,602

The Joint Commission 2,431

American Osteopathic Association 110

AABB 219

American Society for Histocompatibility and Immunogenetics 124

Page 5: Laboratory Reporting Over Direct Background & Implementation Guidance

5

Why is CLIA an issue?• Sec. §493.1291 Standard: Test report

– The laboratory must have adequate manual or electronic systems in place to ensure test results and other patient-specific data are accurately and reliably sent from the point of data entry (whether interfaced or entered manually) to final report destination, in a timely manner.

– Test results must be released only to authorized persons and, if applicable, the individual responsible for using the test results and the laboratory that initially requested the test.

• Sec. §493.1299 Standard: Postanalytic systems assessment – The laboratory must establish and follow written policies and procedures

for an ongoing mechanism to monitor, assess and, when indicated, correct problems identified in the postanalytic systems specified in Sec. 493.1291.

Page 6: Laboratory Reporting Over Direct Background & Implementation Guidance

6

Direct – Laboratory Reporting Workgroup

• ONC formed a workgroup including labs, accrediting agencies, and CLIA– Chairs: Bob Dieterle, John Hall

– Members include: ONC, LabCorp, Quest, Methodist Hospital, Pathology Inc., College of American Pathologists (CAP), CLIA

• Charge:1. Identify any regulatory and operational issues with Direct that prevent or limit

adoption by clinical laboratories for transmitting the “Report of Record” to the Final Report Destination

2. Identify mitigation strategies for each of the issues

3. For regulatory issues, work with ONC and CMS/CLIA to ensure that, where appropriate, guidance is issued to accrediting agencies to enable the use of Direct for lab reporting

Page 7: Laboratory Reporting Over Direct Background & Implementation Guidance

7

Direct – Laboratory Reporting Workgroup In Scope / Out of Scope• In Scope

– Use of Direct messaging to deliver report images• Comparison to FAX or remote teleprinter delivery today

– Use of Direct messaging to deliver laboratory information (test orders and results) – specifically focused for Meaningful Use Phase 1 on the structured data delivery of the “report of record”

• Comparison to current electronic interface approach today (for example)– HL7 MLLP over VPN– HL7 via SOAP

• Out of Scope– Any requirement that “raises the bar” when using Direct versus the

currently accepted equivalent electronic exchange method– Interface certification/validation (e.g. visual verification) -- except

where the use of Direct creates new issues– Reporting to patients

Page 8: Laboratory Reporting Over Direct Background & Implementation Guidance

8

Direct – Laboratory Reporting WorkgroupEffort Sequence and Timeline• Establish issues workgroup• Develop and agree on issues, if any• Review issues with ONC• ONC review of issues with CMS/CLIA

• Expand workgroup to address mitigation • Develop “comprehensive” mitigation list• Prioritize by specific metrics (time, cost,

impact)• Review prioritized list with ONC and create

final list• ONC review of mitigation approach with

CMS/CLIA

• Effort, Implement and Test

Phase 112 weeks

Phase 28-12 weeks

Pilot

Page 9: Laboratory Reporting Over Direct Background & Implementation Guidance

9

Direct – Laboratory Reporting WorkgroupPartial List of Definitions Used

Term Definition

Authorized Person Authorized person means an individual authorized under State law to order tests and receive the report of record

Agent An individual or entity legally acting on behalf of the authorized person to receive test results

Final Report Destination The authorized person or their designated agent

Report of Record The Report of Record is the set of all preliminary, partial, final and corrected reports delivered to the Authorized Person or their Agent at the Final Report Destination

Page 10: Laboratory Reporting Over Direct Background & Implementation Guidance

Laboratory Results Reporting Today

Fax

Remote Print

Terminal or portal

Letter mail

EHR

Lab report Print Image

HL7 over VPN or SOAPLIS or HIS system

Phone

Courier DeliveredLaboratory

Physician office

HIE Web Services

All electronic methods provide some form of positive or negative acknowledgement of receipt 10

Page 11: Laboratory Reporting Over Direct Background & Implementation Guidance

Electronic Laboratory Results Reporting via Direct

Terminal or portal

EHR

Lab report Print Image

LIS or HIS system

Laboratory

Physician office

HIE (Optional)

HL7 over VPN or SOAP

SMTP / MIME

(Public Internet)

HISP - A HISP - B

E-Mail Server

Security Agent

E-Mail Server

Security Agent

SOAP/XD, Other Edge Protocols

Web Services

SMTP/MIME, SOAP/XD, Other Edge Protocols

HL7 over VPN or SOAP

11

Multiple paths are possible depending on the specific implementation of Direct

Direct (SMTP / SMIME)

Page 12: Laboratory Reporting Over Direct Background & Implementation Guidance

12

• Timely and predictable acknowledgement of delivery success or failure– Under CLIA, labs are responsible for delivering reports to the Final Report

Destination, and must know when report delivery has succeeded or failed– Existing mechanisms for report delivery provide timely and predictable

acknowledgement of success and failures

• Direct Project’s Applicability Statement for Secure Health Transport specification allows for acknowledgements of delivery success or failure, but does not require them– Security/Trust Agents (STAs), such as HISPs, that receive a Direct

Message MUST acknowledge successful receipt and trust verification of a Message by sending a Message Disposition Notification (MDN) with a processed disposition (i.e., a processed MDN)

– STAs / HISPs MAY issue other notifications under other conditions but are not required to do so

Direct – Laboratory Reporting WorkgroupConcerns with using Direct

Page 13: Laboratory Reporting Over Direct Background & Implementation Guidance

13

Lab Reporting Over Direct SubgroupSubgroup of Direct Project’s Implementation Geographies Workgroup formed to develop an implementation guide detailing how to implement timely, predictable positive and negative acknowledgement of delivery within a Direct context

• Andre Hebert (Harris)

• Bob Dieterle (ONC)

• Christine Phillips (Harris)

• Greg Meyer (Cerner, Direct Project Reference Implementation WG)

• Joe Lamy (ONC)

• John Hall (ONC, Direct Project)

• Lin Wan (OptumInsight)

• Paul Tuten (ONC, Direct Project Implementation Geographies WG)

• Roy Tharpe (Harris)

• Seonho Kim (ApeniMED)

• Vincent Lewis (GSI Health)

Page 14: Laboratory Reporting Over Direct Background & Implementation Guidance

14

Implementation Guide for Destination Delivery Notification in Direct• Guide details how to implement timely, predictable

acknowledgement of positive or negative delivery within a Direct context

• Requires HISPs to indicate successful or failed delivery to destinations

• Guide details how to request destination delivery notifications, what constitutes a delivery “success” or “failed” notification, and the responsibilities of the Sending and Receiving HISPs around these notifications

• Guide provides use cases that illustrate when and under what circumstances “success” and “failed” notifications could be sent

Page 15: Laboratory Reporting Over Direct Background & Implementation Guidance

15

Notification in a single HISP environment (both parties using same HISP)

• In a single HISP environment, the HISP positively knows when delivery to a destination (i.e., Receiver’s system or inbox) has succeeded or failed

• Requirement: Must notify or indicate back to the Sending system successful or failed delivery to the destination

Page 16: Laboratory Reporting Over Direct Background & Implementation Guidance

16

Notification in a dual-HISP environment (each party using a different HISP)• The Sender and Receiver (e.g., lab and ordering

provider) may be using two different HISPs, a Sending HISP and Receiving HISP

• The Sending HISP on its own cannot tell when delivery to the destination (i.e., Receiver’s system or inbox) has succeeded, so each of the HISPs – Receiving and Sending – have certain requirements that must be met

Page 17: Laboratory Reporting Over Direct Background & Implementation Guidance

17

Notification requirements for Receiving HISPs1. Must provide destination delivery notification messages

upon request

2. Must notify Sending HISP upon successful delivery to a destination by issuing a positive destination delivery notification message (i.e., a “successful delivery” message)

3. Must notify Sending HISP upon failure to deliver to a destination by issuing a negative destination delivery notification message (i.e., a “failed delivery” message)

Page 18: Laboratory Reporting Over Direct Background & Implementation Guidance

18

Notification requirements for Sending HISPs1. Must request destination delivery notification messages from Receiving

HISP

2. Must notify or indicate back to the Sending system of failure to deliver to Receiving HISP

3. Must notify or indicate back to the Sending system failed or successful delivery to the destination based on any received positive or negative destination delivery notification messages

4. Must notify or indicate back to the Sending system failed delivery to the destination if no processed MDN has been received from Receiving HISP within a reasonable timeframe

5. Must notify or indicate back to the Sending system failed delivery to the destination if no destination delivery notification messages have been received from Receiving HISP within a reasonable timeframe

Page 19: Laboratory Reporting Over Direct Background & Implementation Guidance

19

Destination Delivery Notification Technical Details• Need for destination delivery notifications is indicated within the Message

Disposition Notification (MDN) request in the headers of the sent message– MDN request is as specified in RFC 3798, Section 2.1– MDN request contains a disposition notification options header per RFC 3798

Section 2.2• Parameter named X-DIRECT-FINAL-DESTINATION-DELIVERY• Importance set to optional to prevent failure notifications from mail user agents –

however, HISPs and Direct gateways MUST honor the request despite the setting of optional

• Value set to true

• Positive destination delivery notification (i.e., “success”)– MDN disposition of dispatched– MDN extension-field of X-DIRECT-FINAL-DESTINATION-DELIVERY

• Negative destination delivery notification (i.e., “failure”)– MDN with a disposition of failed– Negative Delivery Status Notification (DSN)

Page 20: Laboratory Reporting Over Direct Background & Implementation Guidance

20

Lab Reporting Over Direct FAQ

1. What constitutes a “reasonable timeframe”?A: In the context of lab reporting, a Sending HISP serving a lab should wait for a destination delivery notification no longer than 1 hour before declaring the transmission a failure unless otherwise specified within an SLA with the lab.

2. Beyond the Implementation Guide, are there any other requirements that must be fulfilled in order to transmit lab reports using Direct?A: Yes. All STAs/HISPs must comply with Direct Project’s Applicability Statement, and parties must continue to meet all their responsibilities as applicable under HIPAA and CLIA and associated guidance.

Page 21: Laboratory Reporting Over Direct Background & Implementation Guidance

21

Questions?